Obbligazioni societarie HIGH YIELD e oltre, verso frontiere inesplorate - Vol. 2

Salve, venerdì scorso e oggi tentato di vendere, senza aver trovato nessuno che esponeva prezzi: Avon 2023, talen us87422vaa61 e il 50% non ritirato con l'offerta su valeant usc94143ae14. Mah...

Salve, oggi sonno riuscito a venderle tutte, ecco i prezzi:
ex veleant USC94143AE14 a 100,082;
avon 2023 US054303BA99 a 98,125;
talen US87422VAA61 a 87,79.

Segnalo che è cambiata la procedura di vendita con IW, l'operatore che raccoglie l'ordine prima di portarlo al desk, lo inserisce in altra macchina per eseguire una simulazione di vendita! I tempi per concludere l'operazione si sono allungati di molto! Mah...
 
Questa è la situazione

With current liabilities at US$643.7m, it appears that the company has been able to meet these obligations given the level of current assets of US$943.3m, with a current ratio of 1.47x. Generally, for Food companies, this is a reasonable ratio since there’s a sufficient cash cushion without leaving too much capital idle or in low-earning investments.


NYSE:DF Historical Debt October 2nd 18
Is DF’s debt level acceptable?
With total debt exceeding equities, DF is considered a highly levered company. This is not uncommon for a small-cap company given that debt tends to be lower-cost and at times, more accessible. But since DF is currently loss-making, sustainability of its current state of operations becomes a concern. Running high debt, while not yet making money, can be risky in unexpected downturns as liquidity may dry up, making it hard to operate.

Hanno recentemente sospeso il dividendo

Dean Foods Company announced earnings results for the fourth quarter ended December 31, 2018. For the fourth quarter, the company announced sales was USD 1,929.480 million compared to USD 1,934.997 million a year ago. Operating loss was USD 263.863 million compared to operating Income of USD 34.007 million a year ago. Net loss was USD 260.117 million compared to net income of USD 52.318 million a year ago. Basic loss per share from continuing operations was USD 2.88 compared to basic earnings per share from continuing operations of USD 0.54 a year ago. Basic loss per share was USD 2.85 compared to basic earnings per share of USD 0.57 a year ago. For the full year, sales was USD 7,755.283 million compared to USD 7,795.025 million a year ago. Operating loss was USD 315.193 million compared to operating Income of USD 87.566 million a year ago. Net loss was USD 326.900 million compared to net income of USD 61.588 million a year ago. Basic loss per share from continuing operations was USD 3.63 compared to basic earnings per share from continuing operations of USD 0.52 a year ago. Basic loss per share was USD 3.58 compared to basic earnings per share of USD 0.68 a year ago. Diluted loss per share was USD 3.58 compared to diluted earnings per share of USD 0.67 a year ago.
Dean Foods Company (NYSE:DF) said it has commenced a review to explore and evaluate potential strategic alternatives to enhance shareholder value. These alternatives could include, among others, continuing to execute on the Company's business plan including an increased focus on certain standalone strategic initiatives, the disposition of certain assets, the formation of a joint venture, a strategic business combination, a transaction that results in private ownership or a sale of the company, or some combination of these. Dean has retained Evercore Group LLC to serve as financial advisor to assist in this review. Gibson, Dunn & Crutcher LLP is acting as the Dean's legal advisor. Chief Executive Officer of Dean Foods. "We are taking vital, transformative actions to maximize the benefits of our scale and position the company for the long term, including implementing an enterprise-wide cost productivity plan and investing in core capabilities, technology, infrastructure, people and systems. As we seek to accelerate our business transformation and enhance shareholder value, the Board has initiated a review of a range of potential strategic alternatives to best position the Company for the future."


Restiamo in tema di HY
 
Banks risk derailing a rescue deal for Europe’s largest zinc producer Nyrstar, threatening thousands of jobs in the process if the company is forced into liquidation. FT
 
Salve, oggi sonno riuscito a venderle tutte, ecco i prezzi:
ex veleant USC94143AE14 a 100,082;
avon 2023 US054303BA99 a 98,125;
talen US87422VAA61 a 87,79.

Segnalo che è cambiata la procedura di vendita con IW, l'operatore che raccoglie l'ordine prima di portarlo al desk, lo inserisce in altra macchina per eseguire una simulazione di vendita! I tempi per concludere l'operazione si sono allungati di molto! Mah...


anch'io oggi ho venduto Avon 2023 @ 99,02
 
Oggi vendute Community Healthcare e Revlon
upload_2019-3-26_19-34-42.png


Ci penso ancora cosa fare su Pride/ensco 2014, Argentina Matusalem....
Per il momento CRC, Fresh Market rimangono in PF
Purtroppo ne ho Eletson, Bristow e Cloud Peak, rimango in atessa di news
 

Users who are viewing this thread

Back
Alto